Factor Vila and other Haemostatic Variables following Bone Marrow Transplantation

Summary Hepatic venocclusive disease causes considerable morbidity and mortality following bone marrow transplantation. There are two hypotheses regarding the aetiology of this syndrome; firstly that changes in plasma coagulation factors and natural anticoagulants lead to a prothrombotic state and secondly that endothelial cell activation stimulates intravascular deposition of fibrin. We have investigated these mechanisms by measuring the changes in proteins C and S and factors VII and X in the post transplant period and by using the plasma concentration of factor Vila as an in vivo marker of potential endothelial cell tissue factor expression. Protein C fell in both allograft and autograft patients but more so in the allografts. Similar results were found for factors VII and X. These changes were predominantly due to hepatic dysfunction induced by the chemo-radiotherapy. Factor Vila levels were unchanged in both the allograft and autograft patients. We conclude that there is no convincing evidence for a procoagulant state following BMT as there are both anticoagulant and procoagulant changes. The absence of any changes in factor Vila levels suggests that tissue factor was not exposed to the general circulation following BMT but does not exclude focal expression at the sites of thrombosis.

[1]  T. Drake,et al.  Expression of tissue factor, thrombomodulin, and E-selectin in baboons with lethal Escherichia coli sepsis. , 1993, The American journal of pathology.

[2]  P. Comp,et al.  Quantitation of activated factor VII levels in plasma using a tissue factor mutant selectively deficient in promoting factor VII activation. , 1993, Blood.

[3]  Gianni,et al.  Naturally occurring anticoagulants and bone marrow transplantation: plasma protein C predicts the development of venocclusive disease of the liver. , 1993, Blood.

[4]  J. Armitage,et al.  High frequency of antithrombin 3 and protein C deficiency following autologous bone marrow transplantation for lymphoma. , 1991, Bone marrow transplantation.

[5]  E. Gluckman,et al.  Liver veno-occlusive disease after bone marrow transplantation changes in coagulation parameters and endothelial markers. , 1991, Thrombosis research.

[6]  R. Marcus,et al.  Changes in the natural anticoagulants following bone marrow transplantation. , 1990, Bone marrow transplantation.

[7]  W. Lehmacher,et al.  Increased serum levels of tumor necrosis factor alpha precede major complications of bone marrow transplantation. , 1990, Blood.

[8]  D. O'Brien The molecular biology and biochemistry of tissue factor. , 1989, Bailliere's clinical haematology.

[9]  C. Esmon,et al.  Tumor necrosis factor leads to the internalization and degradation of thrombomodulin from the surface of bovine aortic endothelial cells in culture. , 1989, Blood.

[10]  H. Prydz,et al.  Cytokine-induced procoagulant activity in monocytes and endothelial cells. Further enhancement by cyclosporine. , 1988, Transplantation.

[11]  F. Appelbaum,et al.  Venocclusive disease of the liver after chemoradiotherapy and autologous bone marrow transplantation. , 1987, Transplantation.

[12]  S. Rapaport,et al.  Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation. , 1987, Blood.

[13]  D. Stern,et al.  Interleukin 1 induces endothelial cell procoagulant while suppressing cell-surface anticoagulant activity. , 1986, Proceedings of the National Academy of Sciences of the United States of America.

[14]  T. Gelehrter,et al.  Thrombin induction of plasminogen activator-inhibitor in cultured human endothelial cells. , 1986, The Journal of clinical investigation.

[15]  Pankaj Sharma,et al.  THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATION , 1985, Transplantation.

[16]  Pankaj Sharma,et al.  Venocclusive Disease of the Liver after Bone Marrow Transplantation: Diagnosis, Incidence, and Predisposing Factors , 1984, Hepatology.

[17]  N. Semeraro,et al.  Cultured human endothelial cells generate tissue factor in response to endotoxin. , 1983, The Journal of clinical investigation.

[18]  K. Kopecky,et al.  An analysis of hepatic venocclusive disease and centrilobular hepatic degeneration following bone marrow transplantation. , 1980, Gastroenterology.